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Introduction.
Observations on American and Soviet astronauts have documented
the association of changes in cardiovascular function during
orthostasis with space flight. A basic understanding of the
Cardiovascular changes occurring in astronauts requires the
determination of cardiac output and total peripheral vascular
resistance as a minimum. In 1982, we selected ultrasound
echocardiography as our means of acquiring this information.
Ultrasound offers a quick, non-invasive and accurate means of
determining stroke volume which, when combined with the blood
pressure and heart rate measurements of the stand test, allows
calculation of changes in peripheral vascular resistance, the
body's major response to orthostatic stress.
Methods.
Pre- and post flight echocardiography during the Shuttle program
began with STS-5 in 1982 (Nov., 1982) as part of DSO 402 (Fluid
Loading Countermeasure). ("DSO" stands for "Detailed
Supplementary Objective," an avenue for collecting operationally-
important medical data on Space Shuttle crewmembers.) It was
performed on a sporadic basis on volunteer crewmembers through
1986. Data from the first several flights was determined from
two-dimensional (2D) echocardiographic images acquired with an
instrument originally designed for obstetric use. In 1983, we
upgraded to the ATL 4000 S/LC, which permitted 2D-guided M-mode
imaging. Two of these units were acquired specifically for
conversion into "flight units" (one primary unit and one backup
unit) allowing data collection by trained crewmembers during
Shuttle flights. The prime flight unit has flown on two Shuttle
missions to date: STS 51-D (Apr., 1985) and STS-32 (Jan., 1990).
Up to three more flights may be accomplished by this unit before
it is retired.
Starting with STS-26 (Sept., 1988), several DSOs using
echocardiography have allowed us to collect information on
changes in cardiovascular function associated with flight
duration (DSO 466), in-flight aerobic exercise (DSQ'476), new
fluid loading prescriptions (DSO 479), the use of LBNP as a
countermeasure (DSO 478), and for correlation with heart rate and
blood pressure immediately after landing (DSO 603). Beginning
with STS-28 (Aug., 1989), we have been using a Biosound Genesis
II echocardiograph with Doppler capability. This allows us to
determine cardiac dimensions in conformance with o_r pre-existing
data base and also to determine aortic flow by Doppler techniques
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without the geometrical assumptions required by calculations
based on M-mode measurements.
Results.
From 1982 through 1989, 54 crewmembers on 16 Shuttle missions
volunteered to be subjects for pre- and post flight
echocardiography. Typically, the ultrasound examination is
performed during the operational Stand Test, a routine assessment
of orthostatic function performed on all Shuttle crewmembers
before launch (about ten days before flight), shortly after
landing, and several days later. Continuous echocardiographic
measurements were made while the cf@wmember was supine for five
minutes, and then when the crewmember was standing upright for
five minutes. The electrocardiogram was recorded continuously,
and blood pressure was determined once per minute. The variables
analyzed were: heart rate (HR), systolic and diastolic pressures
(SBP and DBP), left ventricular end-diastolic and end-systolic
dimensions, left ventricular wall thicknesses, right ventricular
end-diastolic dimensions, left atrial and aortic dimensions,
Velocity of circumferential fiber shortening (VCF, and index of
contractility), and (using Doppler) left ventricular inflow and
outflow velocities. Hemodynamic parameters derived from these
measurements included: mean and pulse arterial blood pressures
(MAP and PP), left ventricular end-diastolic, end-systolic and
stroke volume indexes (LVEDVI, LVESVI and LVSI), ejection
fraction (EF), cardiac index (CI) and total peripheral resistance
index (TPRI). The use of hemodynamic indexes normalizes for
differences in body surface area between crewmembers. All
crewmembers used the operational fluid loading protocol shortly
before landing.
Briefly, the pre-Challenger data (collected only during the
supine portion of the stand test) showed that left ventricular
dimensions were reduced by an average of 25% after flights of 5-8
days duration; as a result, the stroke volume is similarly
reduced.
Subsequently, DSO 466 allowed measurements to be made with the
crewmember resting supine (actually left-lateral decubitus) and
then while standing upright, during the operational stand test.
Supine and standing HR were increased by 23% and 35% (p<0.0001)
on landing day compared to preflight. The HR response to
orthostasis was also increased (p<0.0001) on landing day. Supine
DBP increased slightly, and supine and standing PP decreased
slightly on landing day. There were no significant differences
in supine or standing SBP or MAP on landing day compared to
preflight. LVEDVI and LVSI were significantly deG_eased by 11.4%
and 16.6% on landing day compared to preflight. TPRI was
significantly greater in the standing position than in the supine
position on all days except landing day.
In-flight measurements made on STS 51-D and STS-32 documented the
decrease in left ventricular dimensions and increase in arterial
pressure over the first 4"5 days in flight. Typically, late in- V
flight measurements reproduced landing day measurements.
Discussion.
Cardiovascular physiological changes associated with short Space
Shuttle flights include decreases in left ventricular end-
diastolic volume and stroke volume indexes compensated for by
increased heart rate to maintain cardiac output. Decreased
LVEDVI follows the reduction in plasma volume known to occur in
weightlessness.
Comparisons with echocardiographic data from the last Skylab crew
and from Soviet Salyut crewmembers showed that the decrease in
cardiac dimensions (and presumably function) occurs rapidly in-
flight and changes only minimally after the first week in
weightlessness.
These results revealed the nearly complete absence of a
peripheral vascular resistance response to orthostasis on landing
day after as little as 4-5 days in weightlessness. This suggests
strongly that even crewmembers who are not syncopal are relying
largely on their physiological reserve mechanisms (such as
increased heart rate) to remain standing. If they were
confronted with an emergency requiring increase performance, a
successful outcome would be in doubt.
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